Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renovascular hypertension

S C Textor1

  • 1Department of Medicine, Mayo Medical School, Rochester, Minnesota.

Endocrinology and Metabolism Clinics of North America
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Renal artery stenosis management focuses on protecting kidney function, not just controlling blood pressure. Balancing revascularization risks against benefits is key for patients with renovascular hypertension.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary mitochondrial DNA copy number identifies renal mitochondrial injury in renovascular hypertensive patients undergoing renal revascularization: A Pilot Study.

Acta physiologica (Oxford, England)·2019
Same author

Editor's Choice - Comparison of Renal Outcomes in Patients Treated by Zenith<sup>®</sup> Fenestrated and Zenith<sup>®</sup> Abdominal Aortic Aneurysm Stent grafts in US Prospective Pivotal Trials.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2017
Same author

Renovascular hypertension 2014: what have we learned from CORAL?

Journal of human hypertension·2014
Same author

The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Glomerular volume and renal histology in obese and non-obese living kidney donors.

Kidney international·2006
Same author

Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Renal artery stenosis (RAS) is a significant concern for internists, often linked to atherosclerosis.
  • Worsening hypertension and declining renal function are common in patients with RAS.
  • Understanding hormonal and hemodynamic effects of vascular lesions aids antihypertensive therapy selection.

Purpose of the Study:

  • To evaluate the shift in indications for renal revascularization in atherosclerotic RAS.
  • To emphasize the importance of renal function preservation over blood pressure control in RAS management.
  • To guide internists in balancing risks and benefits of revascularization versus medical therapy.

Main Methods:

  • Review of current understanding of hormonal and hemodynamic consequences of RAS.

Related Experiment Videos

  • Analysis of the evolving role of antihypertensive agents, including renin-angiotensin system blockers.
  • Assessment of indications for percutaneous angioplasty and surgical revascularization.

    • Main Results:

    • Blood pressure control is often secondary to renal function protection in RAS management.
    • Renal function preservation is increasingly the primary indication for revascularization procedures.
    • Both percutaneous angioplasty and surgical revascularization carry inherent risks.

    Conclusions:

    • Optimal management of renovascular hypertension requires balancing revascularization risks with benefits.
    • Internists must weigh cardiovascular/cerebrovascular risks against blood pressure control and renal function progression.
    • Further prospective studies are needed to clarify outcomes of medical therapy versus revascularization for RAS.